サマリー

本レポートでは、細菌性膣炎治療薬の市場について調査しています。細菌性膣炎治療薬は、過剰な細菌によって引き起こされる膣の病気である膣内細菌症（BV）の治療に使用され、また、ガードネラ膣炎としても知られています。本レポートでは、メトロニダゾール、クリンダマイシン製剤、その他の薬剤を紹介しています。
市場の分析と洞察細菌性膣炎治療薬の世界市場
細菌性膣炎治療薬の世界市場規模は、2021年の9億1650万米ドルから2028年には1億1300万米ドルに達すると予測され、2022年から2028年の間にCAGR3.0％で推移する見込みです。
世界の細菌性膣炎薬の主要プレイヤーは、Bayer、Pfizer、Sanofi、Piramal、Abbottなどです。世界の上位5社のシェアは約20%。最大の市場は北米と欧州で、ともに約30％のシェアを持ち、次いで中国が約10％のシェアを占めています。製品別では、OTCが最大のセグメントで、約70％のシェアを占めています。また、用途別では、薬局が最も多く、次いで病院等となっています。
本レポートは、業界標準の分析精度と高いデータ整合性により、世界の細菌性膣炎治療薬市場で利用可能な主要機会を明らかにし、プレイヤーが市場で確固たる地位を獲得するのに役立つ素晴らしい試みとなっています。本レポートの購入者は、世界の細菌性膣炎治療薬市場の全体規模（収益ベース）を含む、検証済みの信頼できる市場予測にアクセスすることができます。
全体として、本レポートは、プレイヤーが競合他社に対する競争力を獲得し、世界の細菌性膣炎治療薬市場における持続的な成功を確実にするために使用できる効果的なツールであることが証明されています。本レポートで提供されるすべての調査結果、データ、情報は、信頼できる情報源の助けを借りて検証され、再確認されています。本レポートを執筆したアナリストは、世界の細菌性膣炎薬市場を詳細に調査するため、ユニークで業界最高の調査・分析アプローチをとっています。
世界の細菌性膣炎治療薬の範囲と市場規模
細菌性膣炎治療薬市場は、プレイヤー別、地域（国）別、タイプ別、用途別に分類されます。世界の細菌性膣炎治療薬市場におけるプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして利用することで、優位に立つことができるようになることでしょう。セグメント別分析では、2017年から2028年までのタイプ別およびアプリケーション別の収益と予測に焦点を当てます。
タイプ別セグメント
Rx
一般用医薬品
用途別セグメント
病院
薬局
その他
会社別
バイエル
ファイザー
サノフィ
ピラマル
アボット社
ガルデルマ
ミッション
アルケム
秀峰
テバ
ペリゴ
西区
HPGC
雲南白耀（Yunnan Baiyao
スターファーマ
小説
エデンブリッジ
地域別
北アメリカ
米国
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
北欧諸国
その他の欧州地域
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
その他のアジア
ラテンアメリカ
メキシコ
ブラジル
ラテンアメリカの残りの地域
中近東・アフリカ
トルコ
サウジアラビア
UAE
MEAの残りの部分

ページTOPに戻る

目次

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bacterial Vaginosis Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Rx
1.2.3 OTC
1.3 Market by Application
1.3.1 Global Bacterial Vaginosis Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Bacterial Vaginosis Drug Market Perspective (2017-2028)
2.2 Bacterial Vaginosis Drug Growth Trends by Region
2.2.1 Bacterial Vaginosis Drug Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Bacterial Vaginosis Drug Historic Market Size by Region (2017-2022)
2.2.3 Bacterial Vaginosis Drug Forecasted Market Size by Region (2023-2028)
2.3 Bacterial Vaginosis Drug Market Dynamics
2.3.1 Bacterial Vaginosis Drug Industry Trends
2.3.2 Bacterial Vaginosis Drug Market Drivers
2.3.3 Bacterial Vaginosis Drug Market Challenges
2.3.4 Bacterial Vaginosis Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bacterial Vaginosis Drug Players by Revenue
3.1.1 Global Top Bacterial Vaginosis Drug Players by Revenue (2017-2022)
3.1.2 Global Bacterial Vaginosis Drug Revenue Market Share by Players (2017-2022)
3.2 Global Bacterial Vaginosis Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Bacterial Vaginosis Drug Revenue
3.4 Global Bacterial Vaginosis Drug Market Concentration Ratio
3.4.1 Global Bacterial Vaginosis Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bacterial Vaginosis Drug Revenue in 2021
3.5 Bacterial Vaginosis Drug Key Players Head office and Area Served
3.6 Key Players Bacterial Vaginosis Drug Product Solution and Service
3.7 Date of Enter into Bacterial Vaginosis Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Bacterial Vaginosis Drug Breakdown Data by Type
4.1 Global Bacterial Vaginosis Drug Historic Market Size by Type (2017-2022)
4.2 Global Bacterial Vaginosis Drug Forecasted Market Size by Type (2023-2028)
5 Bacterial Vaginosis Drug Breakdown Data by Application
5.1 Global Bacterial Vaginosis Drug Historic Market Size by Application (2017-2022)
5.2 Global Bacterial Vaginosis Drug Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Bacterial Vaginosis Drug Market Size (2017-2028)
6.2 North America Bacterial Vaginosis Drug Market Size by Type
6.2.1 North America Bacterial Vaginosis Drug Market Size by Type (2017-2022)
6.2.2 North America Bacterial Vaginosis Drug Market Size by Type (2023-2028)
6.2.3 North America Bacterial Vaginosis Drug Market Share by Type (2017-2028)
6.3 North America Bacterial Vaginosis Drug Market Size by Application
6.3.1 North America Bacterial Vaginosis Drug Market Size by Application (2017-2022)
6.3.2 North America Bacterial Vaginosis Drug Market Size by Application (2023-2028)
6.3.3 North America Bacterial Vaginosis Drug Market Share by Application (2017-2028)
6.4 North America Bacterial Vaginosis Drug Market Size by Country
6.4.1 North America Bacterial Vaginosis Drug Market Size by Country (2017-2022)
6.4.2 North America Bacterial Vaginosis Drug Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Bacterial Vaginosis Drug Market Size (2017-2028)
7.2 Europe Bacterial Vaginosis Drug Market Size by Type
7.2.1 Europe Bacterial Vaginosis Drug Market Size by Type (2017-2022)
7.2.2 Europe Bacterial Vaginosis Drug Market Size by Type (2023-2028)
7.2.3 Europe Bacterial Vaginosis Drug Market Share by Type (2017-2028)
7.3 Europe Bacterial Vaginosis Drug Market Size by Application
7.3.1 Europe Bacterial Vaginosis Drug Market Size by Application (2017-2022)
7.3.2 Europe Bacterial Vaginosis Drug Market Size by Application (2023-2028)
7.3.3 Europe Bacterial Vaginosis Drug Market Share by Application (2017-2028)
7.4 Europe Bacterial Vaginosis Drug Market Size by Country
7.4.1 Europe Bacterial Vaginosis Drug Market Size by Country (2017-2022)
7.4.2 Europe Bacterial Vaginosis Drug Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Bacterial Vaginosis Drug Market Size (2017-2028)
8.2 Asia-Pacific Bacterial Vaginosis Drug Market Size by Type
8.2.1 Asia-Pacific Bacterial Vaginosis Drug Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Bacterial Vaginosis Drug Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Bacterial Vaginosis Drug Market Share by Type (2017-2028)
8.3 Asia-Pacific Bacterial Vaginosis Drug Market Size by Application
8.3.1 Asia-Pacific Bacterial Vaginosis Drug Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Bacterial Vaginosis Drug Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Bacterial Vaginosis Drug Market Share by Application (2017-2028)
8.4 Asia-Pacific Bacterial Vaginosis Drug Market Size by Region
8.4.1 Asia-Pacific Bacterial Vaginosis Drug Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Bacterial Vaginosis Drug Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Bacterial Vaginosis Drug Market Size (2017-2028)
9.2 Latin America Bacterial Vaginosis Drug Market Size by Type
9.2.1 Latin America Bacterial Vaginosis Drug Market Size by Type (2017-2022)
9.2.2 Latin America Bacterial Vaginosis Drug Market Size by Type (2023-2028)
9.2.3 Latin America Bacterial Vaginosis Drug Market Share by Type (2017-2028)
9.3 Latin America Bacterial Vaginosis Drug Market Size by Application
9.3.1 Latin America Bacterial Vaginosis Drug Market Size by Application (2017-2022)
9.3.2 Latin America Bacterial Vaginosis Drug Market Size by Application (2023-2028)
9.3.3 Latin America Bacterial Vaginosis Drug Market Share by Application (2017-2028)
9.4 Latin America Bacterial Vaginosis Drug Market Size by Country
9.4.1 Latin America Bacterial Vaginosis Drug Market Size by Country (2017-2022)
9.4.2 Latin America Bacterial Vaginosis Drug Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bacterial Vaginosis Drug Market Size (2017-2028)
10.2 Middle East & Africa Bacterial Vaginosis Drug Market Size by Type
10.2.1 Middle East & Africa Bacterial Vaginosis Drug Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Bacterial Vaginosis Drug Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Bacterial Vaginosis Drug Market Share by Type (2017-2028)
10.3 Middle East & Africa Bacterial Vaginosis Drug Market Size by Application
10.3.1 Middle East & Africa Bacterial Vaginosis Drug Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Bacterial Vaginosis Drug Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Bacterial Vaginosis Drug Market Share by Application (2017-2028)
10.4 Middle East & Africa Bacterial Vaginosis Drug Market Size by Country
10.4.1 Middle East & Africa Bacterial Vaginosis Drug Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Bacterial Vaginosis Drug Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Bayer Business Overview
11.1.3 Bayer Bacterial Vaginosis Drug Introduction
11.1.4 Bayer Revenue in Bacterial Vaginosis Drug Business (2017-2022)
11.1.5 Bayer Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Bacterial Vaginosis Drug Introduction
11.2.4 Pfizer Revenue in Bacterial Vaginosis Drug Business (2017-2022)
11.2.5 Pfizer Recent Developments
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Bacterial Vaginosis Drug Introduction
11.3.4 Sanofi Revenue in Bacterial Vaginosis Drug Business (2017-2022)
11.3.5 Sanofi Recent Developments
11.4 Piramal
11.4.1 Piramal Company Details
11.4.2 Piramal Business Overview
11.4.3 Piramal Bacterial Vaginosis Drug Introduction
11.4.4 Piramal Revenue in Bacterial Vaginosis Drug Business (2017-2022)
11.4.5 Piramal Recent Developments
11.5 Abbott
11.5.1 Abbott Company Details
11.5.2 Abbott Business Overview
11.5.3 Abbott Bacterial Vaginosis Drug Introduction
11.5.4 Abbott Revenue in Bacterial Vaginosis Drug Business (2017-2022)
11.5.5 Abbott Recent Developments
11.6 Galderma
11.6.1 Galderma Company Details
11.6.2 Galderma Business Overview
11.6.3 Galderma Bacterial Vaginosis Drug Introduction
11.6.4 Galderma Revenue in Bacterial Vaginosis Drug Business (2017-2022)
11.6.5 Galderma Recent Developments
11.7 Mission
11.7.1 Mission Company Details
11.7.2 Mission Business Overview
11.7.3 Mission Bacterial Vaginosis Drug Introduction
11.7.4 Mission Revenue in Bacterial Vaginosis Drug Business (2017-2022)
11.7.5 Mission Recent Developments
11.8 Alkem
11.8.1 Alkem Company Details
11.8.2 Alkem Business Overview
11.8.3 Alkem Bacterial Vaginosis Drug Introduction
11.8.4 Alkem Revenue in Bacterial Vaginosis Drug Business (2017-2022)
11.8.5 Alkem Recent Developments
11.9 Xiuzheng
11.9.1 Xiuzheng Company Details
11.9.2 Xiuzheng Business Overview
11.9.3 Xiuzheng Bacterial Vaginosis Drug Introduction
11.9.4 Xiuzheng Revenue in Bacterial Vaginosis Drug Business (2017-2022)
11.9.5 Xiuzheng Recent Developments
11.10 Teva
11.10.1 Teva Company Details
11.10.2 Teva Business Overview
11.10.3 Teva Bacterial Vaginosis Drug Introduction
11.10.4 Teva Revenue in Bacterial Vaginosis Drug Business (2017-2022)
11.10.5 Teva Recent Developments
11.11 Perrigo
11.11.1 Perrigo Company Details
11.11.2 Perrigo Business Overview
11.11.3 Perrigo Bacterial Vaginosis Drug Introduction
11.11.4 Perrigo Revenue in Bacterial Vaginosis Drug Business (2017-2022)
11.11.5 Perrigo Recent Developments
11.12 West-Ward
11.12.1 West-Ward Company Details
11.12.2 West-Ward Business Overview
11.12.3 West-Ward Bacterial Vaginosis Drug Introduction
11.12.4 West-Ward Revenue in Bacterial Vaginosis Drug Business (2017-2022)
11.12.5 West-Ward Recent Developments
11.13 HPGC
11.13.1 HPGC Company Details
11.13.2 HPGC Business Overview
11.13.3 HPGC Bacterial Vaginosis Drug Introduction
11.13.4 HPGC Revenue in Bacterial Vaginosis Drug Business (2017-2022)
11.13.5 HPGC Recent Developments
11.14 Yunnan Baiyao
11.14.1 Yunnan Baiyao Company Details
11.14.2 Yunnan Baiyao Business Overview
11.14.3 Yunnan Baiyao Bacterial Vaginosis Drug Introduction
11.14.4 Yunnan Baiyao Revenue in Bacterial Vaginosis Drug Business (2017-2022)
11.14.5 Yunnan Baiyao Recent Developments
11.15 Starpharma
11.15.1 Starpharma Company Details
11.15.2 Starpharma Business Overview
11.15.3 Starpharma Bacterial Vaginosis Drug Introduction
11.15.4 Starpharma Revenue in Bacterial Vaginosis Drug Business (2017-2022)
11.15.5 Starpharma Recent Developments
11.16 Novel
11.16.1 Novel Company Details
11.16.2 Novel Business Overview
11.16.3 Novel Bacterial Vaginosis Drug Introduction
11.16.4 Novel Revenue in Bacterial Vaginosis Drug Business (2017-2022)
11.16.5 Novel Recent Developments
11.17 Edenvridge
11.17.1 Edenvridge Company Details
11.17.2 Edenvridge Business Overview
11.17.3 Edenvridge Bacterial Vaginosis Drug Introduction
11.17.4 Edenvridge Revenue in Bacterial Vaginosis Drug Business (2017-2022)
11.17.5 Edenvridge Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer